These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25728741)

  • 1. [Usefulness of octreotride in preventing non-variceal gastroinetestinal bleeding in liver cirrhosis: A report of two cases].
    Sort P; Isava A; Porta F; Llao J; Puig I; Vida F
    Gastroenterol Hepatol; 2015; 38(6):386-7. PubMed ID: 25728741
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide bolus injection and azygos blood flow in patients with cirrhosis: is the effect really predictable?
    Spahr L; Giostra E; Mentha G; Hadengue A
    J Clin Gastroenterol; 2010 Oct; 44(9):e206-9. PubMed ID: 19996986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shunting: a better way to prevent variceal bleeding.
    Pedroso FE; Koniaris LG
    J Surg Res; 2011 May; 167(1):e1-3. PubMed ID: 21324391
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-acting octreotide is effective in the treatment of portal hypertensive colopathy.
    Branco JC; Carvalho R; Alberto SF; Reis J
    Gastroenterol Hepatol; 2017 Oct; 40(8):536-537. PubMed ID: 28012579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure].
    Rivera M; Lucero J; Guerrero A; Márquez JL; Montes R; Suñer M; Ruiz A; Valdivia MA; Mateos J
    Nefrologia; 2005; 25(3):332-5. PubMed ID: 16053016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Somatostatin, octreotide and portal hypertension].
    Silvain C; Besson I; Beauchant M
    Gastroenterol Clin Biol; 1994; 18(8-9):761-6. PubMed ID: 7875447
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.
    Nojkov B; Cappell MS
    World J Gastroenterol; 2016 Jan; 22(1):446-66. PubMed ID: 26755890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
    Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
    Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis.
    Ozsoylu S; Koçak N; Demir H; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 2000; 42(1):31-3. PubMed ID: 10731866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between portal hypertension, ascites, gastro-esophageal varices, and gastrointestinal bleeding in patients with alcoholic cirrhosis (author's transl)].
    Doffoel M; Brandt CM; Fincker JL; Bockel R
    Gastroenterol Clin Biol; 1980 May; 4(5):376-82. PubMed ID: 6967436
    [No Abstract]   [Full Text] [Related]  

  • 11. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
    Schepke M
    Dtsch Med Wochenschr; 2009 Sep; 134(37):1823-7. PubMed ID: 19728251
    [No Abstract]   [Full Text] [Related]  

  • 13. Portal hypertension and variceal hemorrhage.
    Sass DA; Chopra KB
    Med Clin North Am; 2009 Jul; 93(4):837-53, vii-viii. PubMed ID: 19577117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
    Garcia-Tsao G; Lim JK;
    Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II].
    Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S
    Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful hemostasis of intractable rectal variceal bleeding using variceal embolization.
    Ahn SS; Kim EH; Kim MD; Lee WJ; Kim SU
    World J Gastroenterol; 2015 Feb; 21(8):2558-62. PubMed ID: 25741168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endoscopy in primary prophylaxis for esophageal variceal bleeding.
    Albillos A; Peñas B; Zamora J
    Clin Liver Dis; 2010 May; 14(2):231-50. PubMed ID: 20682232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated jejunal varices: a cause of occult gastrointestinal hemorrhage in a cirrhotic patient with mild portal hypertension.
    Shussman N; Lalazar G; Bloom AI
    Clin Gastroenterol Hepatol; 2012 May; 10(5):A32. PubMed ID: 22289869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.